Walden Behavioral Care

Mental Health Programs Inc. is dedicated to enhancing the quality of life for individuals through supportive housing and various community-focused initiatives in Spencer, MA. Their Senior Living at Prouty program offers a range of free activities and events, including educational presentations, musical performances, and history showcases that foster community engagement. With a commitment to cultural enrichment, the organization hosts diverse programs funded by local grants, inviting residents and the public to participate and connect. These events not only provide entertainment but also celebrate local history and community heritage, reinforcing Mental Health Programs Inc.'s role as a vital resource in the Spencer area. Generated from the website

Advocates, Inc. in Waltham, MA is a comprehensive rehabilitation and support system catering to clients with disabilities. Their diverse programs encompass substance abuse treatment, psychiatric emergency services, family support, employment and vocational services, day habilitation, and more. The organization has a proven track record of assisting individuals with developmental and intellectual disabilities, mental health concerns, chemical dependencies, hearing impairments, brain injuries, and other related issues. Advocates, Inc. is dedicated to providing essential services and support to help clients achieve their fullest potential and lead fulfilling lives. Generated from their available business information

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website